Baxter International IncBAX
What Baxter International Inc does.
Baxter International Inc., through our subsidiaries, provides a broad portfolio of essential healthcare products, including sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. These products are used by hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers and patients at home under physician supervision. Our global footprint and the critical nature of our products and services play a key role in expanding access to healthcare in emerging and developed countries. As of December 31, 2025, after giving effect to the sale of our Kidney Care business (as discussed below), we manufactured products in over 20 countries and sold them in over 100 countries.
Baxter International Inc. was incorporated under Delaware law in 1931. As used in this report, “we", "our” or "us" means Baxter International Inc. and its consolidated subsidiaries, unless the context otherwise requires.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $11.7B | $12.1B | $10.1B | $10.4B | $10.6B | $11.2B |
| Net income | $1.1B | $1.3B | -$2.4B | $2.7B | -$649.0M | -$957.0M |
| Free cash flow | $1.2B | $1.5B | $834.0M | $1.3B | $573.0M | $332.0M |
More on BAX.
- Baxter International Inc summary
- Baxter International Inc financial statements
- Baxter International Inc key metrics
- Baxter International Inc health scores and style box
- Baxter International Inc earnings
- Baxter International Inc dividends
- Baxter International Inc valuation
- Baxter International Inc ownership and insiders
- Baxter International Inc peers
Figures from Baxter International Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.